Breaking News

How the FDA does and doesn't use expert panels; United Healthcare restricts coverage of Aduhelm

 

Pharmalot Ed Silverman

STAT+: Is the FDA taking advice from its expert panels? A new analysis points to inconsistencies in the process

By Ed Silverman

Sarah Silbiger/Getty Images

"Our study found inconsistency at every stage in the advisory committee process," Joseph Daval, one of the authors of the analysis.

Read More

STAT+: U.N. committee urges wealthy nations to honor human rights and widen access to Covid vaccines

By Ed Silverman

Adobe

A U.N. committee urged wealthy nations to support a proposal before the World Trade Organization to widen access to Covid-19 vaccines.

Read More

STAT+: FDA suspends early study of Vertex stem-cell therapy for type 1 diabetes

By Adam Feuerstein

Bill Sikes/AP

The agency's decision to place a clinical hold on Vertex’s diabetes therapy called VX-880 was a “surprise,” the company told STAT.

Read More

STAT+: UnitedHealthcare restricts coverage of Aduhelm, following Medicare

By Bob Herman

Jessica Rinaldi/Boston Globe

UnitedHealthcare restricts coverage of Aduhelm, and called the Alzheimer’s drug “unproven and not medically necessary.”

Read More

Monday, May 2, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments